Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Molecular Cancer

Fig. 3

From: Imaging metabolic heterogeneity in cancer

Fig. 3

a Endogenous fluorescence images of NADH and FAD lifetimes in organoids derived from triple negative breast cancer (TNBC) and HER2+ tumors. Adapted by permission from the American Association for Cancer Research: Walsh AJ, Cook RS, Sanders ME, Aurisicchio L, Ciliberto G, Arteaga CL, Skala MC: Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. Cancer Res 2014, 74:5184-5194 [124]. b Radioluminescence microscopy of single MDA-MB-231 human breast cancer cells that have taken up FDG

Back to article page